Aqueous humour levels of asymmetric dimethylarginine (ADMA) are correlated with pigment epithelium-derived factor (PEDF) in patients with uveitis

Journal of International Medical Research

Volumn 35, Issue 6, 2007, Pages 892-895

  Yoshida, Y ^a   Yamagishi, Sho Ichi ^a   Ueda, S ^a   Yoshimura, K ^a   Okuda, S ^a   Yamakawa, R ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asymmetric dimethylarginine (ADMA); Nitric oxide; Oxidative stress; Pigment epithelium derived factor (PEDF); Uveitis

Indexed keywords

N(G),N(G) DIMETHYLARGININE; PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; AQUEOUS HUMOR; ARTICLE; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; UVEITIS;

EID: 36949040175     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500618     Document Type: Article

References (14)

1. Tombran-Tink J, Barnstable CJ: PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci 2003; 4: 628-636.
2. Dawson DW, Volpert OV, Gillis P, et al: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245-248.
3. Yamagishi S, Amano S, Inagaki Y, et al: Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Microvasc Res 2003; 65: 186-190.
4. Yamagishi S, Matsui T, Nakamura K, et al: Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis. Microvasc Res 2006; 72: 86-90.
5. Zhang SX, Wang JJ, Gao G, et al: Pigment epithelium-derived factor (PEDF) is an endogenous anti-inflammatory factor. FASEB J 2006; 20: 323-325.
6. Yamagishi S, Matsu T, Nakamura K, et al: Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res 2007; 39: 92-97.
7. Yoshida Y, Yamagishi S, Matsui T, et al: Increased levels of pigment epithelium-derived factor in aqueous humor of patients with uveitis. Br J Ophthalmol 2007; 91: 149-150.
8. Yoshida Y, Yamagishi S, Matsui T, et al: Positive correlation between pigment epithelium-protein-1 levels in the aqueous humour of patients with uveitis. Br J Ophthalmol 2007; 91: 737-738.
9. Goureau O, Bellot J, Thillaye B, et al: Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol 1995; 154: 6518-6523.
10. Rocha G, Baines MG, Deschenes J, et al: Nitric oxide and transforming growth factor-beta levels during experiment uveitis in the rabbit. Can J Ophthalmol 1997; 32: 17-24.
11. Yilmaz G, Sizmaz S, Yilmaz ED, et al: Aqueous humor nitric oxide levels in patients with Behçet disease. Retina 2002; 22: 330-335.
12. Matsumoto Y, Ueda S, Yamagishi S et al: Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol 2007; 18: 1525-1533.
13. Matsuguma K, Ueda S, Yamagishi S, et al: Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 2006; 17: 2176-2183.
14. Yamagishi S, Adachi H, Abe A, et al: Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 2447-2450.